Clinical Trial Update: Losartan and Simvastatin in Hypertensive Obeses With Liver Steatosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating losartan and simvastatin in hypertensive obese patients with liver steatosis; status information is not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• Losartan (losartan)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: University of Pavia | Conditions: Hypertension | Phase 4 | Status: UNKNOWN